Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Evolus Affirms FY2025 Sales Guidance of $295.000M-$305.000M vs $295.999M Est

Author: Benzinga Newsdesk | November 05, 2025 04:21pm
Evolus (NASDAQ:EOLS) affirms FY2025 sales outlook from $295.000 million-$305.000 million to $295.000 million-$305.000 million vs $295.999 million estimate.

Posted In: EOLS


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist